Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome-Reference-Cited by-同舟云学术

Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome

Published:2003-05 Issue:5 Volume:14 Page:745-751
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Constans M.,Sureda A.,Terol M.J.,Arranz R.,Caballero M.D.,Iriondo A.,Jarque I.,Carreras E.,Moraleda J.M.,Carrera D.,León A.,López A.,Albó C.,Díaz-Mediavilla J.,Fernández-Abellán P.,García-Ruiz J.C.,Hernández-Navarro F.,Mataix R.,Petit J.,Pascual M.J.,Rifón J.,García-Conde J.,Fernández-Rañada J.M.,Mateos M.V.,Sierra J.,Conde E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/5/745/568310/mdg206.pdf

Reference23 articles.

1. Twenty years of MOPP therapy for Hodgkin’s disease;Longo;J Clin Oncol,1986

2. Combined modality therapy for advanced Hodgkin’s disease: 15 year follow-up data;Prosnitz;J Clin Oncol,1988

3. Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin’s disease after combination chemotherapy: the low probability for cure;Longo;J Clin Oncol,1992

4. Outcome of patients with Hodgkin’s disease failing after primary MOPP-ABVD;Bonfante;J Clin Oncol,1997

5. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors